Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-09-26

Clinical Trial Update: Dexamethasone for the Prevention of Recurrent Laryngeal Nerve Palsy

View source ↗

Summary

A completed clinical trial evaluating dexamethasone for preventing recurrent laryngeal nerve palsy in patients with thyroid neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Università degli Studi dell'Aquila | Conditions: Benign Neoplasm of Thyroid Gland, Malignant Neoplasm of Thyroid | Status: COMPLETED